161 related articles for article (PubMed ID: 20398054)
1. DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas.
Amara K; Ziadi S; Hachana M; Soltani N; Korbi S; Trimeche M
Cancer Sci; 2010 Jul; 101(7):1722-30. PubMed ID: 20398054
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
Jahangiri R; Jamialahmadi K; Gharib M; Emami Razavi A; Mosaffa F
Gene; 2019 Feb; 685():24-31. PubMed ID: 30359738
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.
Bai X; Song Z; Fu Y; Yu Z; Zhao L; Zhao H; Yao W; Huang D; Mi X; Wang E; Zheng Z; Wei M
PLoS One; 2012; 7(6):e40024. PubMed ID: 22768205
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab.
Zhao H; Zhang LE; Guo S; Yuan T; Xia B; Zhang L; Zhang Y
Oncol Lett; 2015 May; 9(5):2307-2312. PubMed ID: 26137062
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients.
Supic G; Kozomara R; Zeljic K; Jovic N; Magic Z
Clin Oral Investig; 2017 Jan; 21(1):173-182. PubMed ID: 26966018
[TBL] [Abstract][Full Text] [Related]
6. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer.
Cao XY; Ma HX; Shang YH; Jin MS; Kong F; Jia ZF; Cao DH; Wang YP; Suo J; Jiang J
World J Gastroenterol; 2014 Jul; 20(25):8201-8. PubMed ID: 25009393
[TBL] [Abstract][Full Text] [Related]
7. DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis.
Yu Z; Xiao Q; Zhao L; Ren J; Bai X; Sun M; Wu H; Liu X; Song Z; Yan Y; Mi X; Wang E; Jin F; Wei M
Mol Carcinog; 2015 Sep; 54(9):707-19. PubMed ID: 24464625
[TBL] [Abstract][Full Text] [Related]
8. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault I; Tozlu S; Lidereau R; Bièche I
Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
[TBL] [Abstract][Full Text] [Related]
10. DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients.
Maric H; Supic G; Kandolf-Sekulovic L; Maric V; Mijuskovic Z; Radevic T; Rajovic M; Magic Z
Melanoma Res; 2019 Dec; 29(6):596-602. PubMed ID: 30950914
[TBL] [Abstract][Full Text] [Related]
11. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b.
Hsieh CL
Mol Cell Biol; 1999 Dec; 19(12):8211-8. PubMed ID: 10567546
[TBL] [Abstract][Full Text] [Related]
12. Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1.
Datta J; Ghoshal K; Sharma SM; Tajima S; Jacob ST
J Cell Biochem; 2003 Apr; 88(5):855-64. PubMed ID: 12616525
[TBL] [Abstract][Full Text] [Related]
13. Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease.
Ben Gacem R; Ben Abdelkrim O; Ziadi S; Ben Dhiab M; Trimeche M
Tumour Biol; 2014 May; 35(5):4047-56. PubMed ID: 24375250
[TBL] [Abstract][Full Text] [Related]
14. Different expression patterns of DNA methyltransferases during horse testis development.
Yi M; Asgenbaatar N; Wang X; Ulaangerel T; Shen Y; Wen X; Du M; Dong X; Dugarjav M; Bou G
Gene; 2024 Aug; 920():148531. PubMed ID: 38705424
[TBL] [Abstract][Full Text] [Related]
15. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
16. Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer.
Xing J; Stewart DJ; Gu J; Lu C; Spitz MR; Wu X
Br J Cancer; 2008 May; 98(10):1716-22. PubMed ID: 18414412
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
Robaina MC; Mazzoccoli L; Arruda VO; Reis FR; Apa AG; de Rezende LM; Klumb CE
Exp Mol Pathol; 2015 Apr; 98(2):200-7. PubMed ID: 25746661
[TBL] [Abstract][Full Text] [Related]
18. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
19. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer.
Ding WJ; Fang JY; Chen XY; Peng YS
Dig Dis Sci; 2008 Aug; 53(8):2083-9. PubMed ID: 18253830
[TBL] [Abstract][Full Text] [Related]
20. Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.
Purkait S; Sharma V; Kumar A; Pathak P; Mallick S; Jha P; Sharma MC; Suri V; Julka PK; Suri A; Sharma BS; Sarkar C
Exp Mol Pathol; 2016 Apr; 100(2):312-20. PubMed ID: 26892683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
